The find led to the development of a new class of obesity and diabetes drugs, including Ozempic
Anorganic bovine matrix/p-15 flow in the treatment of periodontal defects: case series with 12 months of follow-up
Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H, Jacobsen SD, Moses AC, Mlck AM, Nielsen HS, Nowak J, Solberg H, Thi TD, Zdravkovic M, Moerch U
Future trials should prioritize sufficient duration ( 1218 months), include high-risk subgroups (e.g., older adults, frail individuals, patients with rapid or marked weight loss, or chronic comorbidities such as chronic kidney disease), and integrate nutritional and resistance training interventions
Devaux, A., Helmer, C., Genuer, R